Advancing Cell Therapy Development with Integrated Analytical and Process Strategies

Cell therapy development requires close integration between process and analytical development to build robust, scalable processes and generate the data needed to support regulatory and commercial goals.

This article explores how Kincell Bio uses integrated strategies—including design of experiments, stage-gate development, RNA sequencing, and customizable flow cytometry methods—to accelerate development, reduce risk, and support informed process decisions.